Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Melgaard

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Sygeplejersken|October 20, 1993
[Education: problems in practical guidance]E Melgaard, B Jensen
Current Therapeutic Research, Clinical and Experimental|April 25, 2022
Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind StudyRamin Tehranchi, Jonas Pettersson, Anita E Melgaard, et al.
Diabetes, Obesity & Metabolism|January 24, 2023
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetesSimon Heller, Tadej Battelino, Timothy S Bailey, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Sygeplejersken|October 20, 1993
[Education: problems in practical guidance]E Melgaard, B Jensen
Current Therapeutic Research, Clinical and Experimental|April 25, 2022
Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind StudyRamin Tehranchi, Jonas Pettersson, Anita E Melgaard, et al.
Diabetes, Obesity & Metabolism|January 24, 2023
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetesSimon Heller, Tadej Battelino, Timothy S Bailey, et al.
Pageof 1